Bile diversion and cyclosporine dosage (Letter) by Andrews, W et al.
After liver transplantation, there are marked variations in 
the enteral absorption of cyclosporine, as judged by whole-
blood cyclosporine concentrations measured with radioimmu-
noassay (1, 2). The absorption is influenced by the presence 
or absence of external bile drainage, a clinically significant 
factor that can be demonstrated by describing a few cases of 
the many that have been encountered. 
Case No.1. A 36-year-old woman who had an orthotopic liver 
transplantation for cholangiocarcinoma, returned more than a 
year later with a rising serum bilirubin. A percutaneous cholan-
giocatheter was inserted, which drained significant amounts of 
bile. Without changing Qer oral cyclosporine dosage, the blood 
cyclosporine level fell over 48 hr from 991 nglml, to 362 nglml. 
The blood cyclosporine level remained in the 300-500 nglml 
range until the tube was clamped, at which time it increased 
from 676 nglml to 1,126 nglml, again without changing the 
oral cyclo$porine dose. (Fig. n 
Case No.2. A 38-year-old mim who underwent an orthotopic 
liver transplantation 8 months earlier was admitted because of 
recurrent fevers and a rising serum bilirubin. Ultrasound ex-
amination showed common bile duct dilatation; a percutaneous 
biliary catheter was inserted. The blood cyclosporine level 
before percutaneous tube insertion was 1,023 ng/ml. Twenty-
four hours after biliary drainage, the cyclosporine concentra-
tion fell to 459 ng/m!. The level remained between 200 and 500 
nglml despite increasing his daily oral dose from 480 mg to 
1,200 mg (Fig. 1). Dilatation of a biliary stricture was performed 
under radiographic control, and eventually the drainage tube 
was clamped and removed. After the tube was clamped, the 
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FIGURE 1. The influence of biliary tube insertion, opening, or 
clamping in three patients, 
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cyclosporine concentration increased from 247 nglml to 1:«1 
ng/m\ over 48 hr, necessitating a major downward revision in 
the daily oral dosage. 
Case No.3. A 56-year-old man had his T tube clamped 311z 
days after orthotopic liver transplantation. He had already 
begun cyclosporine bY,the oral route, and had resumed a diet. 
The blood level of cyclosporine rose over the next 24 hr to the 
toxic level of 2,251 nglml (Fig. 1). His serum transaminaaea 
and BUN increased, and he developed malaise and upper ex. 
tremity tremors. His T tube was un clamped and his blood 
cyclosporine level fell precipitously over the next 3 days. Later 
his T tube was clamped ~gain before its removal, with a prompt 
tripling of the cyclosporine blood level (Fig. 1). 
The correlation between cutaneous bile diversion and whole. 
blood cyclosporine levels is well shown in these 3 examples, 
and can be demonstrated quite clearly in virtually every similar 
case. Because cyclosporine is fat-soluble, its efficient absorption 
presumably is dependent -on the bile salts that are removed 
with bile diversion. 
- At one time, 'it was thought th~t cyclosporine h-ad a signifi-
cant en~rohepatic circulation (3). If so, interruption of this 
cycle could be a factor. However, recent studies by Venkatara. 
manan et al. (2) have shown the enterohepatic circulation of 
cyclosporine to be toO minor to account for the major effect of 
bile diversion herein described. 
Whatever the explanation, adjustments in cyclosporine dos-
age must be considered whenever external bile diversion is 
instituted or discontinued. The changes are best guided by 
pharmacologic monitoring. 
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